Product Information
FLAREX 0.1% EYE DROPS is a brand product labeled by Eyevance Pharmaceuticals, LLC, priced at $23.9463 per ML under NDC 71776010005. Its NADAC has been published 325 times since Jul 15, 2020.
FDA first approved this application on Feb 11, 1986.
Strength
1 mg/mL
Manufacturer
Eyevance Pharmaceuticals, LLCNDC
71776010005
Classification
Brand
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
FLUOROMETHOLONE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA019079FDA Approved
2/11/1986
On Market Since
3/5/2019
Pharmacological Classes
Price Statistics
The NADAC for FLAREX 0.1% EYE DROPS has been published 325 times since Jul 15, 2020, and over the history we have for it it has risen 38.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.9463 per ML |
|---|---|
| All-time high | $24.0243 (Feb 12, 2025) |
| All-time low | $17.2563 (Jul 15, 2020) |
| 52-week high | $23.9647 |
| 52-week low | $23.9177 |
| Median price | $23.9733 |
| Average price | $23.5066 |
| Largest weekly change | +32.4% (Nov 4, 2020) |
| Weeks tracked | 325 |
| Tracking since | Jul 15, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluorometholone acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eyevance Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluorometholone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLAREX 0.1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for FLAREX 0.1% EYE DROPS, manufactured by Eyevance Pharmaceuticals, LLC, is $23.9463 per ML (NDC 71776010005), effective Sep 30, 2026.
How has the price of FLAREX 0.1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for FLAREX 0.1% EYE DROPS has risen 38.8%. It has been tracked across 325 weekly CMS publications since Jul 15, 2020.
What are the highest and lowest recorded NADAC prices for FLAREX 0.1% EYE DROPS?
Since Jul 15, 2020, the NADAC for FLAREX 0.1% EYE DROPS has ranged from a low of $17.2563 (Jul 15, 2020) to a high of $24.0243 (Feb 12, 2025), with a median of $23.9733 per ML.
Are there cheaper alternatives to FLAREX 0.1% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of FLAREX 0.1% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLAREX 0.1% EYE DROPS?
FLAREX 0.1% EYE DROPS (NDC 71776010005) is labeled by Eyevance Pharmaceuticals, LLC, and CMS classifies it as a brand product.